American Journal of Transplantation
The use of a Bluetooth tablet‐based technology to improve outcomes in lung transplantation: A pilot study
The impact of remote patient monitoring platforms to support the post‐operative care of solid organ transplant recipients is evolving. In an observational pilot study, 28 lung transplant recipients were enrolled in a novel post‐discharge home monitoring program and compared to 28 matched controls during a two‐year period. Primary endpoints included hospital readmissions and total days readmitted. Secondary endpoints were survival and inflation‐adjusted hospital readmission charges. In univariate analyses, monitoring was associated with reduced readmissions (IRR: 0.56; 95% CI: 0.41 – 0.76; p < 0.001), days readmitted (IRR: 0.46; 95% CI: 0.42 – 0.51; p < 0.001), and hospital charges (IRR: 0.52; 95% CI: 0.51 – 0.54; p < 0.001). Multivariate analyses also showed that remote monitoring was associated with lower incidence of readmission (IRR: 0.38; 95% CI: 0.23 – 0.63; p < 0.001), days readmitted (IRR: 0.14; 95% CI: 0.05 – 0.37; p < 0.001), and readmission charges (IRR: 0.11; 95% CI: 0.03 – 0.46; p = 0.002). There were 2 deaths among monitored patients compared to 6 for controls; however, this difference was not significant. This pilot study in lung transplant recipients suggests that supplementing post‐discharge care with remote monitoring may be useful in preventing readmissions, reducing subsequent inpatient days, and controlling hospital charges. A multicenter, randomized control trial should be conducted to validate these findings.
Source: American Journal of Transplantation